These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 38523222)
1. Neuropsychiatric comorbidities in tuberous sclerosis complex patients with epilepsy: results of the TAND checklist survey. Lee HY; Lin CH; Wang XA; Tsai JD Acta Neurol Belg; 2024 Jun; 124(3):973-979. PubMed ID: 38523222 [TBL] [Abstract][Full Text] [Related]
2. The TAND checklist: a useful screening tool in children with tuberous sclerosis and neurofibromatosis type 1. Cervi F; Saletti V; Turner K; Peron A; Bulgheroni S; Taddei M; La Briola F; Canevini MP; Vignoli A Orphanet J Rare Dis; 2020 Sep; 15(1):237. PubMed ID: 32894194 [TBL] [Abstract][Full Text] [Related]
3. Seizure freedom but not epilepsy surgery is associated with fewer neuropsychiatric difficulties in patients with tuberous sclerosis. Pearsson K; Eklund EA; Rask O; Compagno-Strandberg M Epilepsy Behav; 2024 Aug; 157():109875. PubMed ID: 38824750 [TBL] [Abstract][Full Text] [Related]
4. Natural clusters of tuberous sclerosis complex (TSC)-associated neuropsychiatric disorders (TAND): new findings from the TOSCA TAND research project. de Vries PJ; Belousova E; Benedik MP; Carter T; Cottin V; Curatolo P; D'Amato L; Beure d'Augères G; Ferreira JC; Feucht M; Fladrowski C; Hertzberg C; Jozwiak S; Lawson JA; Macaya A; Marques R; Nabbout R; O'Callaghan F; Qin J; Sander V; Sauter M; Shah S; Takahashi Y; Touraine R; Youroukos S; Zonnenberg B; Kingswood JC; Jansen AC; J Neurodev Disord; 2020 Sep; 12(1):24. PubMed ID: 32873244 [TBL] [Abstract][Full Text] [Related]
5. Tuberous sclerosis-associated neuropsychiatric disorders: a paediatric cohort study. Toldo I; Brasson V; Miscioscia M; Pelizza MF; Manara R; Sartori S; Mantegazza G; Vecchi M; Nosadini M; Gatta M Dev Med Child Neurol; 2019 Feb; 61(2):168-173. PubMed ID: 30298907 [TBL] [Abstract][Full Text] [Related]
6. Tuberous Sclerosis Complex Associated Neuropsychiatric Disorders and Parental Stress: Findings from a National, Prospective TSC Surveillance Study. Ebrahimi-Fakhari D; Hussong J; Flotats-Bastardas M; Ebrahimi-Fakhari D; Zemlin M; von Gontard A; Meyer S Neuropediatrics; 2019 Oct; 50(5):294-299. PubMed ID: 31266065 [TBL] [Abstract][Full Text] [Related]
7. [Neuropsychiatric manifestations in Tuberous Sclerosis Complex (TSC): diagnostic guidelines, TAND concept and therapy with mTOR inhibitors]. Waltereit R; Feucht M; de Vries MC; Huemer J; Roessner V; de Vries PJ Z Kinder Jugendpsychiatr Psychother; 2019 Mar; 47(2):139-153. PubMed ID: 30080117 [TBL] [Abstract][Full Text] [Related]
8. Tuberous sclerosis associated neuropsychiatric disorders (TAND) and the TAND Checklist. de Vries PJ; Whittemore VH; Leclezio L; Byars AW; Dunn D; Ess KC; Hook D; King BH; Sahin M; Jansen A Pediatr Neurol; 2015 Jan; 52(1):25-35. PubMed ID: 25532776 [TBL] [Abstract][Full Text] [Related]
9. TSC-associated neuropsychiatric disorders (TAND): findings from the TOSCA natural history study. de Vries PJ; Belousova E; Benedik MP; Carter T; Cottin V; Curatolo P; Dahlin M; D'Amato L; d'Augères GB; Ferreira JC; Feucht M; Fladrowski C; Hertzberg C; Jozwiak S; Kingswood JC; Lawson JA; Macaya A; Marques R; Nabbout R; O'Callaghan F; Qin J; Sander V; Sauter M; Shah S; Takahashi Y; Touraine R; Youroukos S; Zonnenberg B; Jansen AC; Orphanet J Rare Dis; 2018 Sep; 13(1):157. PubMed ID: 30201051 [TBL] [Abstract][Full Text] [Related]
10. Measurement of Developmental and Behavioral Concerns in Toddlers With Tuberous Sclerosis Complex. McDonald NM; Jacobs S; Hyde C; Kasari C; Jeste SS Pediatr Neurol; 2024 Jun; 155():62-67. PubMed ID: 38603983 [TBL] [Abstract][Full Text] [Related]
11. A clinical update on tuberous sclerosis complex-associated neuropsychiatric disorders (TAND). de Vries PJ; Wilde L; de Vries MC; Moavero R; Pearson DA; Curatolo P Am J Med Genet C Semin Med Genet; 2018 Sep; 178(3):309-320. PubMed ID: 30117265 [TBL] [Abstract][Full Text] [Related]
12. Behavioral problems and family distress in tuberous sclerosis complex. Uematsu M; Numata-Uematsu Y; Aihara Y; Kobayashi T; Fujikawa M; Togashi N; Shiihara T; Ohashi K; Hattori A; Saitoh S; Kure S Epilepsy Behav; 2020 Oct; 111():107321. PubMed ID: 32698109 [TBL] [Abstract][Full Text] [Related]
13. Symptom rates and profile clustering in tuberous sclerosis complex-associated neuropsychiatric disorders (TAND). Alperin S; Krueger DA; Franz DN; Agricola KD; Stires G; Horn PS; Capal JK J Neurodev Disord; 2021 Dec; 13(1):60. PubMed ID: 34903167 [TBL] [Abstract][Full Text] [Related]
14. Is It Feasible to Identify Natural Clusters of TSC-Associated Neuropsychiatric Disorders (TAND)? Leclezio L; Gardner-Lubbe S; de Vries PJ Pediatr Neurol; 2018 Apr; 81():38-44. PubMed ID: 29530301 [TBL] [Abstract][Full Text] [Related]
15. Pilot validation of the tuberous sclerosis-associated neuropsychiatric disorders (TAND) checklist. Leclezio L; Jansen A; Whittemore VH; de Vries PJ Pediatr Neurol; 2015 Jan; 52(1):16-24. PubMed ID: 25499093 [TBL] [Abstract][Full Text] [Related]
16. Sleep disorders and neuropsychiatric disorders in a pediatric sample of tuberous sclerosis complex: a questionnaire-based study. Moavero R; Voci A; La Briola F; Matricardi S; Toldo I; Mancardi MM; Negrin S; Messana T; Mazzone L; Valeriani M; Curatolo P; Bruni O Sleep Med; 2022 Jan; 89():65-70. PubMed ID: 34915263 [TBL] [Abstract][Full Text] [Related]
17. Tuberous Sclerosis Complex Patients' Needs and Difficulties-Results of TAND Questionnaire Analysis in Polish Adult Population. Marcinkowska AB; Jóźwiak S; Tarasewicz A; Dębska-Ślizień A; Szurowska E J Clin Med; 2022 Nov; 11(21):. PubMed ID: 36362764 [TBL] [Abstract][Full Text] [Related]
18. Epilepsy and Neurodevelopmental Comorbidities in Tuberous Sclerosis Complex: A Natural History Study. Gupta A; de Bruyn G; Tousseyn S; Krishnan B; Lagae L; Agarwal N; Pediatr Neurol; 2020 May; 106():10-16. PubMed ID: 32139167 [TBL] [Abstract][Full Text] [Related]
19. The research landscape of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND)-a comprehensive scoping review. Vanclooster S; Bissell S; van Eeghen AM; Chambers N; De Waele L; Byars AW; Capal JK; Cukier S; Davis P; Flinn J; Gardner-Lubbe S; Gipson T; Heunis TM; Hook D; Kingswood JC; Krueger DA; Kumm AJ; Sahin M; Schoeters E; Smith C; Srivastava S; Takei M; Waltereit R; Jansen AC; de Vries PJ J Neurodev Disord; 2022 Feb; 14(1):13. PubMed ID: 35151277 [TBL] [Abstract][Full Text] [Related]